Genomictree지노믹트리
228760 · KOSDAQ · ₩228760 · 지노믹트리
₩9,970▲ ₩70 (0.71%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩3.8B | ₩2.4B | ₩3.4B | ₩30B | ₩5.1B |
| Cost of sales | ₩3B | ₩3.1B | ₩3.7B | ₩4.9B | ₩2.6B |
| Gross profit | ₩714M | −₩727M | −₩270M | ₩25B | ₩2.5B |
| Operating income | −₩11B | −₩15B | −₩17B | ₩2.4B | −₩9.9B |
| Net income | −₩9.1B | −₩10B | −₩9B | — | — |
| Net income to shareholders | −₩9B | −₩10B | −₩8.8B | −₩6.6B | −₩11B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩121B | ₩131B | ₩133B | ₩163B | ₩177B |
| Current assets | ₩79B | ₩98B | ₩95B | ₩118B | ₩134B |
| Cash and equivalents | ₩16B | ₩26B | ₩45B | ₩68B | ₩66B |
| Total liabilities | ₩5.5B | ₩6.4B | ₩7.8B | ₩55B | ₩62B |
| Current liabilities | ₩4.4B | ₩4.8B | ₩5.3B | ₩53B | ₩2.1B |
| Borrowings | ₩2.3B | ₩2B | ₩1.7B | ₩29B | ₩37B |
| Total equity | ₩115B | ₩124B | ₩125B | ₩108B | ₩115B |
| Shareholders' equity | ₩115B | ₩124B | ₩125B | ₩107B | ₩115B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩10B | −₩14B | −₩11B | ₩4.3B | −₩7.6B |
| Capital spending | ₩2.7B | ₩2.5B | ₩239M | ₩1.8B | ₩11B |
| Free cash flow | −₩13B | −₩16B | −₩11B | ₩2.5B | −₩19B |
Consolidated where available. Amounts in won.
Also known as: Genomictree / 지노믹트리 / 228760 / KRX:228760
Source: KRX statistical information